Rheumatic Disease clinical trials

Explore recruiting rheumatic disease clinical trials.

Recruiting rheumatic disease studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rheumatic Disease trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Characterization of the immune response in immunosuppressed patients with rheumatic diseases, including to the recombinant zoster vaccine

France

Therapeutic use (Phase IV) EU CTIS Study details

Vaccination against respiratory syncytial virus in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on the RSV immune response.

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Evaluating the safety of shortened infusion tiMes for dIfferent oNcological immUnoThErapies; An observational prospective study (MINUTE)

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Randomized clinical trial to assess the efficacy and safety of a strategy for primary prevention of cardiovascular disease in patients with inflammatory rheumatic diseases based on the use of carotid ultrasound.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Optimising Arthritis Strategies in Elderly patients (≥70 years) with rheumatoid arthritis in sustained low disease activity (the OASE study): A Prospective Target Trial Emulation Study Evaluating Tapering of Disease-Modifying Anti-Rheumatic Drugs vs. Usual Care Based on Patient Preference

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

Rheumatic Disease trials by city

Rheumatic Disease in Toronto Rheumatic Disease in Vancouver Rheumatic Disease in Montreal Rheumatic Disease in Calgary Rheumatic Disease in Edmonton Rheumatic Disease in Ottawa Rheumatic Disease in Winnipeg Rheumatic Disease in Quebec City Rheumatic Disease in Hamilton Rheumatic Disease in Kitchener Rheumatic Disease in London Rheumatic Disease in Halifax Rheumatic Disease in New York Rheumatic Disease in Los Angeles Rheumatic Disease in Chicago Rheumatic Disease in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease